U.S. Food and Drug Administration. (n.d.). MCM Legal, Regulatory and Policy Framework. (Accessed 1/16/2020.)
The FDA works within this framework to ensure that U.S. laws, regulations and policies help support preparedness and response for potential chemical, biological, radiological, nuclear (CBRN) and emerging infectious disease threats. This webpage includes links to related legislation, emergency use authorities of the FDA, and legal and policy presentations, publications, and other information.